Clinical Trials and Efficacy Assessment in the Therapy of Cutaneous T Cell Lymphoma

: The ability of clinical trials to measure cutaneous T cell lymphoma (CTCL) has allowed physicians and regulatory reviewers to assess the response of the disease to experimental therapies. The goals of therapy are remission, palliation, and improvement of survival. Given the chronic nature of the d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of the New York Academy of Sciences 2001-09, Vol.941 (1), p.155-165
1. Verfasser:	HEALD, PETER
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers - analysis clinical trials Clinical Trials as Topic Erythema - diagnosis Gene Rearrangement, T-Lymphocyte Humans Lymphoma, T-Cell, Cutaneous - diagnosis Lymphoma, T-Cell, Cutaneous - genetics Lymphoma, T-Cell, Cutaneous - therapy Palliative Care Polymerase Chain Reaction Quality of Life Recurrence Skin Neoplasms - diagnosis Skin Neoplasms - genetics Skin Neoplasms - therapy skin scoring methods Terminology as Topic therapy of cutaneous T cell lymphoma Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!